ADAMs contribute to triple negative breast cancer via mTORC1 pathway: targeting ADAM-mTOR axis improves efficacy.
Saved in:
| Title: | ADAMs contribute to triple negative breast cancer via mTORC1 pathway: targeting ADAM-mTOR axis improves efficacy. |
|---|---|
| Authors: | Liu S; Department of Breast Medical Oncology, USA. Electronic address: sliu@mdanderson.org., Chen H; Department of Breast Medical Oncology, USA; Department of of Biostatistics, USA., Gagea M; Department of Veterinary Medicine and Surgery, USA., Federico L; Department of System Biology, USA., Zhang F; Department of System Biology, USA., Gomez J; Department of Leukemia, USA., Do KA; Department of of Biostatistics, USA., Symmans WF; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hortobagyi GN; Department of Breast Medical Oncology, USA., Mills GB; Department of System Biology, USA., Gonzalez-Angulo AM; Department of Breast Medical Oncology, USA., Tripathy D; Department of Breast Medical Oncology, USA. |
| Source: | Cancer letters [Cancer Lett] 2025 Aug 28; Vol. 626, pp. 217775. Date of Electronic Publication: 2025 May 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
